Solanesol: a promising natural product
Frontiers in Pharmacology · 24.03.2025 · 16
DOI: 10.3389/fphar.2025.1504245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.03.2025. Verfasst von Yinchao Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Life Science Academy, Beijing, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Solanesol, identified as Nonaprenol alcohol, predominates in the Solanaceae family. This compound exists as a white to pale yellow solid at room temperature, characterized by low polarity and water insolubility. Its unique chemical structure—featuring nine non-conjugated double bonds and low polarity—confers remarkable biological activities. Recent studies have demonstrated that solanesol exhibits polypharmacological properties, including antimicrobial, antioxidant, anti-inflammatory, and membrane-stabilizing effects. Mechanistically, solanesol suppresses ROS generation and inhibits pro-inflammatory cytokines (IL-1β, TNF-α). Preclinical studies highlight its therapeutic potential in inflammatory disorders (periodontitis, neuropathic pain) and neurodegenerative diseases (Alzheimer’s, Parkinson’s). However, current research still faces critical bottlenecks, such as a lack of in vivo pharmacokinetic data, unclear molecular targets, and insufficient toxicity assessments. Future studies urgently need to integrate experimental approaches, including target screening, nanotechnology-based delivery systems, and multi-omics analysis, to elucidate its mechanisms of action and promote clinical translation. As a compound that combines natural safety with multi-target effects, solanesol is not only a research focus for the development of novel drugs but also a bridge connecting natural products and precision medicine, poised to lead the innovation of next-generation biocompatible therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Life Science Academy, Beijing, China.
- NHC Key Laboratory of Medical Immunology (Peking University), School of Basic Medical Sciences, Peking University, Beijing, China.
Zitieren
APA
Ma, Y., Wei, G., Dong, Z., Wang, Z., Zhai, X., Liu, Y., Chen, H., Fu, Y., Hou, H., Hu, Q., & Chu, M. (2025). Solanesol: a promising natural product. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1504245
Vancouver
Ma Y, Wei G, Dong Z, Wang Z, Zhai X, Liu Y, et al. Solanesol: a promising natural product. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1504245
BibTeX
@article{Ma2025,
author = {Ma, Yinchao and Wei, Ge and Dong, Zhichen and Wang, Ziyuan and Zhai, Xinlong and Liu, Yuan and Chen, Huan and Fu, Yaning and Hou, Hongwei and Hu, Qingyuan and Chu, Ming},
title = {Solanesol: a promising natural product},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1504245}
}
EUVIMED